Presurgical Clinical Characteristics Stratified by Availability of Follow-Up Values
. | . | Readings Within 3–18 mo . | . | . | |
---|---|---|---|---|---|
Variable . | Overall . | No . | Yes . | P . | Reference Range . |
N | 407 | 263 | 144 | ||
Sex | |||||
Female | 328 (80.6) | 207 | 121 (84) | ||
Male | 79 (19.45) | 56 | 23 (16) | 0.277 | |
Age | 57.57 ± 13.92, n = 395 | 57.38 ± 13.77, n = 254 | 57.90 ± 14.24, n = 141 | 0.723 | |
BMI | 30.28 ± 7.60, n = 314 | 30.76 ± 7.59, n = 192 | 29.53 ± 7.6, n = 122 | 0.165 | |
Calcium | 11 [10.6–11.4], n = 399 | 10.9 [10.6–11.4], n = 257 | 11.1 [10.6–11.4], n = 142 | 0.373 | 8.5–10.2 mg/dL |
24-h urine calcium | 284 [182–393], n = 114 | 280 [193–396], n = 64 | 296 [176–385], n = 50 | 0.782 | 100–300 mg/24 h |
Creatinine | 0.86 [0.73–1], n = 379 | 0.86 [0.72–1], n = 242 | 0.84 [0.74–1], n = 137 | 0.459 | 0.6–1 mg/dL |
Phosphorus | 3.06 ± 0.54, n = 306 | 3.01 ± 0.54, n = 188 | 3.13 ± 0.54, n = 118 | 0.05 | 2.9–4.7 mg/dL |
PTH | 125.4 [91.8–174.9], n = 361 | 130.7 [93.1–183.5], n = 224 | 122.8 [85–168.9], n = 137 | 0.159 | 12–72 pg/mL |
Vitamin D | 30.63 ± 12.55, n = 129 | 29.34 ± 11.79, n = 78 | 32.61 ± 13.51, n = 51 | 0.145 | 20–80 ng/mL |
. | . | Readings Within 3–18 mo . | . | . | |
---|---|---|---|---|---|
Variable . | Overall . | No . | Yes . | P . | Reference Range . |
N | 407 | 263 | 144 | ||
Sex | |||||
Female | 328 (80.6) | 207 | 121 (84) | ||
Male | 79 (19.45) | 56 | 23 (16) | 0.277 | |
Age | 57.57 ± 13.92, n = 395 | 57.38 ± 13.77, n = 254 | 57.90 ± 14.24, n = 141 | 0.723 | |
BMI | 30.28 ± 7.60, n = 314 | 30.76 ± 7.59, n = 192 | 29.53 ± 7.6, n = 122 | 0.165 | |
Calcium | 11 [10.6–11.4], n = 399 | 10.9 [10.6–11.4], n = 257 | 11.1 [10.6–11.4], n = 142 | 0.373 | 8.5–10.2 mg/dL |
24-h urine calcium | 284 [182–393], n = 114 | 280 [193–396], n = 64 | 296 [176–385], n = 50 | 0.782 | 100–300 mg/24 h |
Creatinine | 0.86 [0.73–1], n = 379 | 0.86 [0.72–1], n = 242 | 0.84 [0.74–1], n = 137 | 0.459 | 0.6–1 mg/dL |
Phosphorus | 3.06 ± 0.54, n = 306 | 3.01 ± 0.54, n = 188 | 3.13 ± 0.54, n = 118 | 0.05 | 2.9–4.7 mg/dL |
PTH | 125.4 [91.8–174.9], n = 361 | 130.7 [93.1–183.5], n = 224 | 122.8 [85–168.9], n = 137 | 0.159 | 12–72 pg/mL |
Vitamin D | 30.63 ± 12.55, n = 129 | 29.34 ± 11.79, n = 78 | 32.61 ± 13.51, n = 51 | 0.145 | 20–80 ng/mL |
Categorical variables (sex) are summarized with counts and (percentages), and tested with a χ2 test. Continuous variables that are sufficiently normal are summarized with means ± SDs, and tested with t tests. Continuous variables that are highly skewed and heteroscedastic are summarized with medians and [quartiles], and tested with the Mann-Whitney U test.
Presurgical Clinical Characteristics Stratified by Availability of Follow-Up Values
. | . | Readings Within 3–18 mo . | . | . | |
---|---|---|---|---|---|
Variable . | Overall . | No . | Yes . | P . | Reference Range . |
N | 407 | 263 | 144 | ||
Sex | |||||
Female | 328 (80.6) | 207 | 121 (84) | ||
Male | 79 (19.45) | 56 | 23 (16) | 0.277 | |
Age | 57.57 ± 13.92, n = 395 | 57.38 ± 13.77, n = 254 | 57.90 ± 14.24, n = 141 | 0.723 | |
BMI | 30.28 ± 7.60, n = 314 | 30.76 ± 7.59, n = 192 | 29.53 ± 7.6, n = 122 | 0.165 | |
Calcium | 11 [10.6–11.4], n = 399 | 10.9 [10.6–11.4], n = 257 | 11.1 [10.6–11.4], n = 142 | 0.373 | 8.5–10.2 mg/dL |
24-h urine calcium | 284 [182–393], n = 114 | 280 [193–396], n = 64 | 296 [176–385], n = 50 | 0.782 | 100–300 mg/24 h |
Creatinine | 0.86 [0.73–1], n = 379 | 0.86 [0.72–1], n = 242 | 0.84 [0.74–1], n = 137 | 0.459 | 0.6–1 mg/dL |
Phosphorus | 3.06 ± 0.54, n = 306 | 3.01 ± 0.54, n = 188 | 3.13 ± 0.54, n = 118 | 0.05 | 2.9–4.7 mg/dL |
PTH | 125.4 [91.8–174.9], n = 361 | 130.7 [93.1–183.5], n = 224 | 122.8 [85–168.9], n = 137 | 0.159 | 12–72 pg/mL |
Vitamin D | 30.63 ± 12.55, n = 129 | 29.34 ± 11.79, n = 78 | 32.61 ± 13.51, n = 51 | 0.145 | 20–80 ng/mL |
. | . | Readings Within 3–18 mo . | . | . | |
---|---|---|---|---|---|
Variable . | Overall . | No . | Yes . | P . | Reference Range . |
N | 407 | 263 | 144 | ||
Sex | |||||
Female | 328 (80.6) | 207 | 121 (84) | ||
Male | 79 (19.45) | 56 | 23 (16) | 0.277 | |
Age | 57.57 ± 13.92, n = 395 | 57.38 ± 13.77, n = 254 | 57.90 ± 14.24, n = 141 | 0.723 | |
BMI | 30.28 ± 7.60, n = 314 | 30.76 ± 7.59, n = 192 | 29.53 ± 7.6, n = 122 | 0.165 | |
Calcium | 11 [10.6–11.4], n = 399 | 10.9 [10.6–11.4], n = 257 | 11.1 [10.6–11.4], n = 142 | 0.373 | 8.5–10.2 mg/dL |
24-h urine calcium | 284 [182–393], n = 114 | 280 [193–396], n = 64 | 296 [176–385], n = 50 | 0.782 | 100–300 mg/24 h |
Creatinine | 0.86 [0.73–1], n = 379 | 0.86 [0.72–1], n = 242 | 0.84 [0.74–1], n = 137 | 0.459 | 0.6–1 mg/dL |
Phosphorus | 3.06 ± 0.54, n = 306 | 3.01 ± 0.54, n = 188 | 3.13 ± 0.54, n = 118 | 0.05 | 2.9–4.7 mg/dL |
PTH | 125.4 [91.8–174.9], n = 361 | 130.7 [93.1–183.5], n = 224 | 122.8 [85–168.9], n = 137 | 0.159 | 12–72 pg/mL |
Vitamin D | 30.63 ± 12.55, n = 129 | 29.34 ± 11.79, n = 78 | 32.61 ± 13.51, n = 51 | 0.145 | 20–80 ng/mL |
Categorical variables (sex) are summarized with counts and (percentages), and tested with a χ2 test. Continuous variables that are sufficiently normal are summarized with means ± SDs, and tested with t tests. Continuous variables that are highly skewed and heteroscedastic are summarized with medians and [quartiles], and tested with the Mann-Whitney U test.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.